Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Start date: Apr 14, 2021 End date: Apr 16, 2021
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease. Radcliffe Cardiology is delighted to announce that Transcatheter Interventions Online (TIO) will return for 2021 on April 14-16th, led by course director, Prof Nicolas van Mieghem from Erasmus MC, Rotterdam, NL. TIO is a free virtual event that brings together… View more
Author(s): Christian Spies , Ziyad M Hijazi Added: 3 years ago
Unlike the left-sided semi-lunar valve, clinically significant acquired pulmonary valve disease is rare. However, stenotic or regurgitant pulmonary valve lesions are not uncommon following surgery for congenital heart defects, including tetralogy of Fallot, pulmonary atresia and other surgical procedures requiring reconstruction of the right ventricular outflow tract (RVOT).1–4 Even with the use… View more
Start date: Mar 26, 2024 End date: Mar 28, 2024
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease. Overview Radcliffe Cardiologyis delighted to announce thatTranscatheter Interventions Online (TIO)will return for 2024 on26-28 March 2024, led by the course director,Prof Nicolas Van Mieghemfrom Erasmus MC, Rotterdam, NL. TIO brings together leading international faculty to create a rich,… View more
TCT Transcatheter Cardiovascular Therapeutics (TCT) is organised by Radcliffe Cardiology partner CardioVascular Research Foundation (CFR).TCT provides physicians opportunities for hands-on training, interactive learning, live case demonstrations, and to network, all with access to world-class KOLs and experts! View more
Author(s): Hellmuth Weich Added: 3 years ago
There has been a recent explosion in the field of transcatheter aortic and pulmonary valve replacements, but the atrio-ventricular valves have lagged behind for various reasons with the tricuspid valve undoubtedly the least treated valve of the four. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, patients are rarely referred for isolated surgical tricuspid… View more
Start date: Mar 15, 2023 End date: Mar 17, 2023
A virtual event dedicated to transcatheter treatment strategies for coronary and structural heart disease. Overview Radcliffe Cardiologyis delighted to announce thatTranscatheter Interventions Online (TIO)will return for 2023 on15 – 17 March 2023, led by the course director,Prof Nicolas Van Mieghemfrom Erasmus MC, Rotterdam, NL. TIO brings together leading international faculty to create a… View more
Author(s): Nicolas M Van Mieghem , Ajay J Kirtane , Holger Thiele , et al Added: 1 month ago
.buttonVideoSeries { width: 90%; /* Set the width of the container */ text-align: left; /* Align buttons to the left */ } .buttonVideoSeries .button { width: 100%; /* Set the width of each button */ text-align: center; /* Center the text within the button */ overflow: hidden; /* Hide any overflow text */ white-space: normal; /* Allow… View more
Author(s): Raquel del Valle-Fernández , Carlos E Ruiz Added: 3 years ago
Mitral regurgitation (MR) is the second most prevalent valvular heart disease in developed countries and nearly one-third of the patients with isolated, native valve disease are diagnosed with significant MR, according to the Euro Heart Survey on Valvular Heart Disease.1 Mitral valve (MV) complex is a very complicated structure which consists of the mitral annulus (MA), valve leaflets, papillary… View more